phosphorylcholine has been researched along with Opportunistic Infections in 5 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Visceral leishmaniasis is an opportunistic infection that affects human immunodeficiency virus-infected persons in leishmaniasis-endemic areas." | 5.36 | Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient. ( Barragán, P; López-Velez, R; Olmo, M; Podzamczer, D, 2010) |
| "Miltefosine has structural similarity to the PC and sphingomyelin substrates of PlcHR, and we found that it inhibits the cleavage of these choline-containing lipids in vitro." | 1.37 | Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. ( Allard, JL; Allen, GB; Gross, MJ; Hogan, DA; Leclair, LW; Lundblad, LK; Rajamani, S; Vasil, ML; Wargo, MJ, 2011) |
| "Visceral leishmaniasis is an opportunistic infection that affects human immunodeficiency virus-infected persons in leishmaniasis-endemic areas." | 1.36 | Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient. ( Barragán, P; López-Velez, R; Olmo, M; Podzamczer, D, 2010) |
| "Miltefosine is a less toxic option to replace the antimony compounds." | 1.34 | [Cutaneous leishmaniasis]. ( Sunderkötter, C; von Stebut, E, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spadari, CC | 1 |
| Vila, T | 1 |
| Rozental, S | 1 |
| Ishida, K | 1 |
| Barragán, P | 1 |
| López-Velez, R | 1 |
| Olmo, M | 1 |
| Podzamczer, D | 1 |
| Wargo, MJ | 1 |
| Gross, MJ | 1 |
| Rajamani, S | 1 |
| Allard, JL | 1 |
| Lundblad, LK | 1 |
| Allen, GB | 1 |
| Vasil, ML | 1 |
| Leclair, LW | 1 |
| Hogan, DA | 1 |
| von Stebut, E | 1 |
| Sunderkötter, C | 1 |
| Wysluch, A | 1 |
| Sommerer, F | 1 |
| Ramadan, H | 1 |
| Loeffelbein, D | 1 |
| Wolff, KD | 1 |
| Hölzle, F | 1 |
1 review available for phosphorylcholine and Opportunistic Infections
| Article | Year |
|---|---|
[The leishmaniasis - a parasitel infection as differential diagnosis of malignant tumours of oral mucosa. A case report and review of literature].
Topics: Animals; Combined Modality Therapy; Diagnosis, Differential; Hepatitis C, Chronic; Histiocytes; Huma | 2007 |
4 other studies available for phosphorylcholine and Opportunistic Infections
| Article | Year |
|---|---|
Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.
Topics: Amphotericin B; Antifungal Agents; Apoptosis; Biofilms; Cell Membrane; Cell Membrane Permeability; C | 2018 |
Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.
Topics: AIDS-Related Opportunistic Infections; HIV; HIV Infections; HIV-1; Humans; Itraconazole; Leishmanias | 2010 |
Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection.
Topics: Animals; Antifungal Agents; Bronchoalveolar Lavage Fluid; Cystic Fibrosis; Disease Models, Animal; H | 2011 |
[Cutaneous leishmaniasis].
Topics: Animals; Biopsy; Cross-Sectional Studies; Diagnosis, Differential; Humans; Leishmania; Leishmaniasis | 2007 |